Charles River Laboratories International share price logo

Charles River Laboratories International Share Price

NYSE: CRL

Mid Cap

$169.00

+4.76

(+2.90%)

as on

Charles River Laboratories International Stock Performance

as on February 21, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $161.85
    $171.93
    downward going graph

    4.23%

    Downside

    1.73%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $91.86
    $228.88
    downward going graph

    45.64%

    Downside

    35.43%

    Upside

    downward going graph

Charles River Laboratories International share price movements today

Previous Close
$164.24
Open
$162.70
Volume
1.1M
Day's Low - High
$161.85 - $171.93
52 Week Low - High
$91.86 - $228.88

Charles River Laboratories International Historical Returns

1 Month Return
-25.51 %
3 Month Return
+ 0.76 %
1 Year Return
+ 3.62 %
3 Year Return
-30.66 %
5 Year Return
-41.66 %

Charles River Laboratories International Stock Fundamentals & Key Indicators

Check Charles River Laboratories International market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.1B

EPS (TTM)

10.96

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.17%

PE Ratio (TTM)

23.31

Industry PE ratio

18.238589743589742

PEG Ratio

0.1185

EBITDA

804.4M

Revenue (TTM)

4.0B

Profit Margin

-3.60%

Return On Equity TTM

-4.23%

Charles River Laboratories International Stock Valuation

Track how Charles River Laboratories International P/E has moved over time to understand its valuation trends.

Charles River Laboratories International in the last 5 years

  • Overview

  • Trends

Lowest (12.45x)

June 30, 2025

Industry (18.24x)

February 21, 2026

Today (23.31x)

February 21, 2026

Highest (40.60x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 23.31x

Charles River Laboratories International vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Charles River Laboratories International with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$8.1B-41.66%23.31-3.60%
BUY$50.5B16.82%48.2924.62%
HOLD$32.7B18.32%31.0120.30%
BUY$193.5B6.7%29.0715.05%
BUY$35.8B-3.13%27.7718.75%

Stock Returns calculator for Charles River Laboratories International Stock including INR - Dollar returns

The Charles River Laboratories International stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Charles River Laboratories International investment value today

Current value as on today

₹1,08,381

Returns

₹8,381

(+8.38%)

Returns from Charles River Laboratories International Stock

₹3,668 (+3.67%)

Dollar Returns*

₹4,713 (+4.71%)

Analyst Recommendation on Charles River Laboratories International Stock

Based on 21 analysts

BUY

61.90%

Buy

38.10%

Hold

0.00%

Sell

Based on 21 analysts, 61.9% of analysts recommend a 'BUY' rating for Charles River Laboratories International. Average target price of $199.2

Charles River Laboratories International Share Price Target

Get share price movements and forecasts by analysts on Charles River Laboratories International.

What analysts predicted

15.16%UPSIDE

Target Price

$199.2

Current Price

$169

Analyzed by

21 Analysts

Target

$199.20

Charles River Laboratories International target price $199.2, a slight upside of 15.16% compared to current price of $169. According to 21 analysts rating.

Charles River Laboratories International Stock’s Investor Sentiment and Interest

Search interest for Charles River Laboratories International Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:100% versus previous 30 day period

Charles River Laboratories International Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
1,026
1,013
1,011
1,026
1,009
1,002
984
1,032
1,004
994
Gross Profit
361
364
344
353
349
284
317
357
338
307
Operating Income
151
132
125
151
117
-167
74
100
133
120
EBITDA
225
322
219
238
209
-86
184
220
197
198
Interest Expense
33
33
35
32
30
28
27
29
25
23
Depreciation
78
80
85
86
88
102
120
119
85
-
Income Before Tax
112
208
99
119
91
-216
35
71
87
-294
Income Tax Expense
24
19
24
25
20
-3
10
18
31
-17
Net Income
87
187
67
89
68
-215
25
52
54
-276
Net Profit Margin
8.51%
18.46%
6.66%
8.77%
6.80%
-21.52%
2.59%
5.07%
5.42%
-27.82%

Charles River Laboratories International Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,681
1,857
2,266
2,621
2,923
3,540
3,976
4,129
4,049
4,015
Gross Profit
643
700
840
958
1,073
1,334
1,462
1,502
1,331
1,225
Operating Income
237
288
331
351
432
589
650
617
227
507
EBITDA
377
457
507
563
768
820
986
1,032
581
911
Interest Expense
27
29
63
60
86
73
59
136
126
107
Depreciation
-
131
161
198
234
265
303
311
361
-
Income Before Tax
222
296
281
304
447
480
622
581
93
-99
Income Tax Expense
66
171
54
50
81
81
130
100
67
42
Net Income
154
123
226
252
364
390
486
474
10
-144
Net Profit Margin
9.20%
6.64%
9.99%
9.61%
12.46%
11.04%
12.23%
11.49%
0.25%
-3.59%

Charles River Laboratories International Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
188
74
94
70
-213
25
52
55
-276
Operating Cash Flow
220
129
193
251
159
171
204
213
147
Investing Cash Flow
-238
-85
-61
-21
-76
-45
-37
-33
-73
Financing Cash Flow
123
18
-285
-207
-75
-105
-226
-152
-51
Change in Cash
118
54
-157
30
-6
26
-46
24
6

Charles River Laboratories International Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
125
227
254
365
398
492
480
25
-142
Operating Cash Flow
316
441
480
546
760
619
683
734
737
Investing Cash Flow
-72
-955
-681
-601
-1,437
-607
-563
-245
-209
Financing Cash Flow
-208
558
231
47
672
-42
-85
-550
-536
Change in Cash
46
30
42
-6
13
-5
43
-78
10

Mutual Funds that own Charles River Laboratories International Stock

Check out the Mutual Funds with significant holdings in Charles River Laboratories International.

Funds
Holdings
Shares Held
Motilal Oswal S&P 500 Index Fund Direct Growth
Motilal Oswal S&P 500 Index Fund Direct Growth
0.0179%
392

Global Institutional Holdings in Charles River Laboratories International

Funds
Holdings
BlackRock Inc
7.43%
State Street Corp
3.78%
Amvescap Plc.
2.51%
Harris Associates L.P.
2.36%
Earnest Partners LLC
2.03%

Charles River Laboratories International News & Key Events

  • img

    Today's Timeline - 18 February

    Wed, 07:22 PM

    -

    Glenn Coleman appointed CFO effective April 6, 2026, bringing extensive healthcare finance experience.

    Wed, 07:25 PM

    -

    CRL reports Q4 2025 adjusted EPS of $2.39, surpassing estimates, but GAAP loss of $5.62 per share.

    Wed, 11:19 PM

    -

    Shares fell 4% after disappointing 2026 revenue forecast amid challenging growth environment.

  • img

    Today's Timeline - 18 February

    Thu, 06:44 AM

    -

    Charles River Laboratories reports Q4 2025 revenue of $994.23 million with a net loss of $276.56 million; new CFO appointed.

Insights on Charles River Laboratories International

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CRL stock has moved up by 4.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Idexx Laboratories, Inc. has given 40.4% return, outperforming this stock by 36.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Idexx Laboratories, Inc. has given 33.5% return, outperforming this stock by 56.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 1.03B → 994.22M (in $), with an average decrease of 1.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 54.42M → -276.55M (in $), with an average decrease of 608.2% per quarter

About Charles River Laboratories International

charles river provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. #drugdiscovery #biotech #biotechnology #pharmaceuticals #cro
OrganisationCharles River Laboratories International
Headquarters251 Ballardvale Street, Wilmington, MA, United States, 01887
IndustryCommercial Services
CEOMr. James C. Foster J.D.
E-voting on sharesClick here to vote

Key Management of Charles River Laboratories International

Name

Title

Ms. Victoria L. Creamer

Corporate Executive VP & Chief People Officer

Mr. Michael Gunnar Knell

Interim CFO, Corporate Senior VP & Chief Accounting Officer

Mr. Todd Spencer

Corporate Vice President of Investor Relations

Mr. Mark Mintz

Corporate EVP, Chief Information Officer & Global Shared Services

Mr. Matthew L. Daniel J.D.

Corporate Senior VP, General Counsel, Corporate Secretary & Chief Compliance Officer

Ms. Amy E. Cianciaruso

Corporate Senior Vice President, Chief Communications Officer & Government Relations

Dr. Brian F. Bathgate Ph.D.

Corporate Senior Vice President of European Safety Assessment

Mr. James C. Foster J.D.

Chairman, President & CEO

Mr. Joseph W. LaPlume J.D.

Corporate Executive Vice President of Corporate Development & Strategy

Prof. Julie Frearson Ph.D.

Corporate Senior VP & Chief Scientific Officer

FAQs

What is Charles River Laboratories International share price today?

Charles River Laboratories International share price today is $169 as on at the close of the market. Charles River Laboratories International share today touched a day high of $171.93 and a low of $161.85.

What is the 52 week high and 52 week low for Charles River Laboratories International share?

Charles River Laboratories International share touched a 52 week high of $228.88 on and a 52 week low of $91.86 on . Charles River Laboratories International stock price today i.e. is closed at $169,which is 26.16% down from its 52 week high and 83.97% up from its 52 week low.

What is Charles River Laboratories International's market capitalisation today?

Charles River Laboratories International market capitalisation is $0.01T as on .

How to invest in Charles River Laboratories International Stock (CRL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Charles River Laboratories International on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Charles River Laboratories International Shares that will get you 0.0089 shares as per Charles River Laboratories International share price of $169 per share as on February 21, 2026 at 2:29 am IST.

What is the minimum amount required to buy Charles River Laboratories International Stock (CRL) from India?

Indian investors can start investing in Charles River Laboratories International (CRL) shares with as little as ₹90.681 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.81 in Charles River Laboratories International stock (as per the Rupee-Dollar exchange rate as on ). Based on Charles River Laboratories International share’s latest price of $169 as on February 21, 2026 at 2:29 am IST, you will get 0.0592 shares of Charles River Laboratories International. Learn more about fractional shares .

What are the returns that Charles River Laboratories International has given to Indian investors in the last 5 years?

Charles River Laboratories International stock has given -41.66% share price returns and 25.33% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?